However, the efficacy of long-acting penicillin for secondary prevention of rheumatic fever has not been widely studied; consequently, the relation between serum levels of long-acting penicillin and inflammatory markers C-reactive protein and interleukin-6 is largely unknown. The gene discussed is CRP; the disease is rheumatic fever.